Allscripts Healthcare Solutions, Inc. (MDRX) Rating Increased to Overweight at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) from a neutral rating to an overweight rating in a research note published on Tuesday, Marketbeat reports. The firm currently has $12.00 price target on the software maker’s stock.

MDRX has been the subject of several other research reports. Bank of America Corporation began coverage on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. They set a neutral rating and a $14.00 price target for the company. Leerink Swann downgraded shares of Allscripts Healthcare Solutions from an outperform rating to a market perform rating and reduced their price target for the company from $15.00 to $13.00 in a report on Monday, June 19th. BidaskClub upgraded shares of Allscripts Healthcare Solutions from a strong sell rating to a sell rating in a research note on Tuesday, June 13th. Maxim Group restated a buy rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, May 5th. Finally, Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a sell rating to a hold rating in a research note on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $14.59.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 12.85 on Tuesday. Allscripts Healthcare Solutions has a 12 month low of $9.80 and a 12 month high of $13.70. The stock’s market cap is $2.32 billion. The firm’s 50-day moving average is $12.50 and its 200-day moving average is $12.19.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The firm had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. During the same period last year, the firm posted $0.14 EPS. The business’s revenue was up 10.2% compared to the same quarter last year. On average, equities analysts forecast that Allscripts Healthcare Solutions will post $0.62 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Allscripts Healthcare Solutions, Inc. (MDRX) Rating Increased to Overweight at Cantor Fitzgerald” was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2017/08/16/allscripts-healthcare-solutions-inc-mdrx-rating-increased-to-overweight-at-cantor-fitzgerald.html.

A number of large investors have recently modified their holdings of the company. FNY Partners Fund LP boosted its stake in shares of Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock valued at $101,000 after buying an additional 7,200 shares during the period. Invictus RG acquired a new stake in shares of Allscripts Healthcare Solutions during the first quarter valued at approximately $105,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Allscripts Healthcare Solutions by 9.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock valued at $120,000 after buying an additional 816 shares during the period. Bank of Montreal Can boosted its stake in shares of Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after buying an additional 3,724 shares during the period. Finally, Flinton Capital Management LLC boosted its stake in shares of Allscripts Healthcare Solutions by 4.1% in the first quarter. Flinton Capital Management LLC now owns 9,940 shares of the software maker’s stock valued at $126,000 after buying an additional 392 shares during the period.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply